For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Obamacare’s subsidy cliff: How many enrollees are actually affected?
Democrats in Congress have put Obamacare front and center in their opposition to the Republicans’ temporary budget. One provision of the American Rescue Plan…
National Review
RFK Jr.’s Cherry-Picked Science
One of Robert F. Kennedy Jr.’s promises as secretary of health and human services was to bring gold-standard science to our public…
Blog
The TrumpRx medicine will prove worse than the disease
On September 30, President Trump, standing alongside the CEO of Pfizer, announced a multifaceted deal wherein Pfizer would inoculate itself from new regulations and…
Search Posts
News Release
Institute Cheers Court Decision, Cautiously: Free Speech Protected, but FDA Regulation of Tobacco Unwarranted
WASHINGTON, DC April 25, 1997 — The Competitive Enterprise Institute gave one cheer for today's federal court ruling that overturned FDA's attempt to restrict…
News Release
Institute Calls for USDA to Truly Reinvent Itself in Wake of Strawberry Fiasco
WASHINGTON, DC April 2, 1997– As thousands of public school students prepare to get hepatitis vaccines due to contaminated school lunch strawberry desserts distributed…
News Release
National Poll on Air Bags Shows Need for Change
WASHINGTON, DC March 28, 1997 — By a ratio of nearly 3 to 1, the public favors giving people the choice of purchasing a…
Study
Sudden Impact: The Collision Between The Air Bag Mandate And Ethics
Full Document Available in PDF Air bags…
News Release
New CEI Study: Promising Treatments Delayed by FDA
Charging that outgoing FDA Commissioner David Kessler has left a legacy of increased bureaucracy and deadly overcaution, the Competitive Enterprise Institute will release a new…
News Release
New FDA Bill Offers Hope for the Desperate
The Access to Medical Treatment Act (H.R. 746 ), a bipartisan bill being introduced in the House today, marks a step forward in both medicine…